Impact of Early Ventilation in Stroke Outcomes in Patients With Sleep Apnea After First Ever Stroke

Recruiting Phase 2 Interventional Study
Stroke Sleep Apnea
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Prevention
Participants needed
90 (estimated)
Sponsor
Philips Portuguesa S.A. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

To evaluate the impact of early ventilation in stroke outcomes in patients with sleep apnea and first ever stroke, 1 month after stroke.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Written informed consent obtained from the participant or the legally acceptable representative, prior to any study-related procedure. 2. Male or female between 18 and 80 years, inclusive, at the time of signing the informed consent. 3. Admission to the hospital within 48 h o…
Contacts

Sílvia Correia, MD

00351969043466

silviapaiscorreia@gmail.com

CONTACT